logo

$5 And Under

Share SHARE

Aldeyra Therapeutics Inc. (ALDX) reported results from its Phase 2a clinical trial of topical ocular ADX-102 in patients with dry eye disease Tuesday morning. The results showed statistically and clinically significant improvement across multiple sign and symptom endpoints. Aldeyra Therapeutics gapped...

Aldeyra Therapeutics Inc. (ALDX) reported results from its Phase 2a clinical trial of topical ocular ADX-102 in patients with dry eye disease Tuesday morning. The results showed statistically and clinically significant improvement across multiple sign and symptom endpoints. Aldeyra Therapeutics gapped...

Aethlon Medical Inc. (AEMD) announced Tuesday morning that it has received an Expedited Access Pathway designation from the FDA to support the advancement of the Aethlon Hemopurifier. Aethlon Medical gapped open sharply higher this morning and is now up 1.46 at $3.46 on the highest volume of the year....

The Guatemalan Supreme Court has reinstated Tahoe Resources Inc.'s (TAHO) Escobal mining license of the company's Guatemalan subsidiary, Minera San Rafael. Tahoe Resources gapped open sharply higher Monday morning and has continued to rise on above average volume. Shares are now up 2.17 at $6.87...

Kura Oncology Inc. (KURA) announced after the close Thursday that its Phase 2 trial of tipifarnib, in patients with HRAS mutant relapsed or refractory squamous cell carcinomas of the head and neck, achieved its primary endpoint. The stock is now up 1.60 on 642K shares. Kura Oncology was range-bound...

Otonomy Inc. (OTIC) announced Wednesday morning that its Phase 3 trial of OTIVIDEX in patients with Ménière's disease missed its primary endpoint. Otonomy gapped open dramatically lower Wednesday morning, but was range-bound throughout the session. The stock closed down by 17.23 at $3.58 on the highest...

Otonomy Inc. (OTIC) announced Wednesday morning that its Phase 3 trial of OTIVIDEX in patients with Ménière's disease missed its primary endpoint. Otonomy has gapped open dramatically lower this morning and is now down 17.28 at $3.53 on the highest volume of the year. The stock has plummeted to a new low for the year.

Dimension Therapeutics Inc. (DMTX) announced Friday morning that it has agreed to be acquired by REGENXBIO Inc. (RGNX) for approximately $3.41 per share in an all-stock transaction. Dimension Therapeutics has gapped open sharply higher this morning and is now up 1.80 at $3.00 on strong volume. The...

The FDA has advised Cardiome Pharma Corp. (CRME) that the data package proposed by the company would not be sufficient to support a resubmission of the BRINAVESS New Drug Application. Cardiome Pharma gapped open lower Monday and dropped in the first hour of trade, before settling into a range. Shares...

Follow RTT